ClinicalTrials.gg
CompletedNCT07803107Updated Oct 20, 2026

Cognitive-Behavioral Psychoeducational Program for Cultural Adaptation and Psychological Resilience Among International Students

An interventional study of Cognitive-Behavioral Psychoeducational Program and Career-Guidance Psychoeducational Program in Acculturative Stress, Psychological Resilience and Psychological Adaptation, sponsored by European University of Lefke. Completed at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by European University of Lefke · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Feb 2025, registered Aug 2026).
Updated Oct 20, 2026Enrollment updatedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Sex
All
01

Study summary

This study evaluated a psychoeducational program developed to support psychological adaptation and resilience among first-year international university students experiencing elevated acculturative stress. Participants who met the study eligibility criteria were assigned to one of three study conditions: a cognitive-behavioral psychoeducation group, a placebo-control group receiving career guidance activities, or a waiting-list control group. The psychoeducational intervention was delivered over eight weeks. Psychological adaptation, resilience, and acculturative stress-related outcomes were assessed using standardized self-report measures before and after the intervention. The study aimed to examine whether participation in the psychoeducational program was associated with changes in these psychological outcomes compared with the two control conditions.

02

Conditions studied

  • Acculturative Stress
  • Psychological Resilience
  • Psychological Adaptation
03

In context

Lead sponsor

European University of Lefke is the lead sponsor of 22 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scoring more than one standard deviation above the overall sample mean on the Acculturative Stress Scale for International Students (ASSIS).
  • Being a first-year international student enrolled at the study university.
  • Providing written .
  • Being able to attend the eight-week intervention program regularly.

Exclusion criteria

Exclusion Criteria:

  • Not meeting the predefined ASSIS criterion for elevated acculturative stress.
  • Not being a first-year international student.
  • Not providing written .
  • Being unable to attend the eight-week intervention program regularly.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    Cognitive-Behavioral Psychoeducation Group

    Participants assigned to this arm received the cognitive-behavioral psychoeducational program developed to support psychological adaptation and resilience and to reduce acculturative stress among international students. The program was delivered over eight weeks.

    Behavioral: Cognitive-Behavioral Psychoeducational Program

  • Active comparator
    Placebo-Control Group

    Participants assigned to this arm received a career-guidance psychoeducational program that did not include the cognitive-behavioral components targeting psychological adaptation, resilience, or acculturative stress.

    Behavioral: Career-Guidance Psychoeducational Program

  • No intervention
    Waiting-List Control Group

    Participants assigned to this arm did not receive a study intervention during the eight-week intervention period and served as a waiting-list control group.

Interventions

  • BehavioralCognitive-Behavioral Psychoeducational Program

    The intervention consisted of a structured cognitive-behavioral psychoeducational program designed to support psychological adaptation and resilience and to address acculturative stress among international students. The program was delivered once weekly for eight weeks, for a total of eight sessions. Sessions included psychoeducational and cognitive-behavioral activities focusing on cultural adaptation, coping with acculturative stress, and psychological resilience.

  • BehavioralCareer-Guidance Psychoeducational Program

    Participants received a career-guidance psychoeducational program designed to provide information and activities related to career development. The program was delivered once weekly for eight weeks, for a total of eight sessions. It did not include the cognitive-behavioral components specifically targeting psychological adaptation, resilience, or acculturative stress.

06

What researchers measure

Primary outcomes

  1. Change in Acculturative Stress

    Acculturative stress was assessed using the Acculturative Stress Scale for International Students (ASSIS), developed by Sandhu and Asrabadi (1994). The ASSIS consists of 36 items rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 36 to 180, with higher scores indicating greater acculturative stress. Change in ASSIS total scores from baseline to post-intervention was evaluated.

    Time frame: Baseline and immediately after the 8-week intervention

07

Study locations

1 site
  • European University of Lefke
    Mersin, Northern Cyprus 99010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2025 to primary completion in May 2025, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 31, 2026
First posted
Sep 3, 2026
StartActual
Feb 24, 2025
Primary completionActual
May 12, 2025
CompletionActual
May 12, 2025
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Enrollment
36→45
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Enrollment 36→45

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07803107
Lead sponsor
European University of Lefke
Responsible party
Dilem Öke (Lecturer, European University of Lefke) — Principal investigator
First posted
Sep 3, 2026
Start date
Feb 24, 2025
Primary completion
May 12, 2025
Completion
May 12, 2025
Last update
Oct 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion